By: Ajay K Malik, PhD Technetium-99m (Tc-99m) is the most used radioactive tracer with over 30 million tests per year done all over the world. When tagged to a pharmaceutical or biological marker, it helps evaluate, diagnose or manage cancer spread, blood flow and cardiac function; brain activity and thyroid disease; and detect osseous metastasis,
The investigational radioisotope, F-18 FLT (fluorothymidine), is showing promise in clinical trials in the ability to assess response to cancer treatment. Research into the clinical applications of the FLT radiotracer has been underway for over 10 years. After FDA approval for use in clinical trials, the molecular imaging community is holding much promise in the
New I123 radiopharmaceutical to image dopamine transporters. By Dr. Kirandeep Kaur
Summary of the radioisotope Amyvid for detection and diagnosis of Alzheimer’s disease. By Charlene Supnet, Ph.D.
Global shortages of Tc-99m have had an impact on the nuclear medicine industry for the past few years. This is a result of the shutdown of at least 2 nuclear reactors, located in Ontario, Canada and Petten, Netherlands, due to safety issues. The Ontario reactor (Chalk River Labs) is where North America gets most of